CLDN4 Palmitoylation Promotes Hepatic-to-Biliary Lineage Transition and Lenvatinib Resistance in Hepatocellular Carcinoma

Investigators identified the hepatic-to-biliary lineage transition, associated with Claudin 4, a tight junction protein, as a potential target for mitigating lenvatinib resistance in HCC.